Primally, they found that TRPV3 levels, measured by Western blotting analysis in human keratinocytes cultures, derived from patients with AD and from an in vivo mice model of AD, are significatively higher and more activated than normal skin keratinocytes or keratinocytes derived from patients with other skin diseases. The gene discussed is TRPV3; the disease is Alzheimer disease.